Off-patent Drugs Bill
A Bill to require the Secretary of State to seek licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.
Legislative progress
Commons
24 Jun 2015
1st reading
Commons
6 Nov 2015
2nd reading
Chamber debates
-
Hansard 6 Nov 2015
-
Hansard 7 Nov 2014